Persistence of Neurological Symptoms Due to Neuroleptic Drugs
Abstract
The author examines the problem of extrapyramidal symptoms attributable to neuroleptic drugs. Thirty-nine patients with tardive dyskinesia and/or pseudoparkinsonism did not receive neuroleptics for six to 24 months. At the end of this time, 36 patients manifested symptoms consistent with tardive dyskinesia. In five of 12 patients who had pseudoparkinsonism, alone or with tardive dyskinesia, parkinsonian symptoms persisted for six months or longer.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).